AstraZeneca: EU approves diabetes pill Qtrilmet
(CercleFinance.com) - The European Commission has approved AstraZeneca's Qtrilmet tablets for improving glycaemic control in adults with type-2 diabetes, the drugmaker said on Friday.
The once-daily oral drug was already approved in the US in May this year.
Copyright (c) 2019 CercleFinance.com. All rights reserved.
The once-daily oral drug was already approved in the US in May this year.
Copyright (c) 2019 CercleFinance.com. All rights reserved.